UCB and Biogen say their first phase 3 trial of systemic lupus erythematosus (SLE) candidate dapirolizumab pegol was a success, with a second planned.

Buoyed by data from a phase 1b/2a trial, Roche has said it plans to start a phase 3 programme for an Alzheimer's drug from its Brainshuttle programme ...

HotHardware is your trusted source for technology news and expert reviews of computers, PC components, laptops, tablets, smartphones and gadgets for enthusiasts, consumers, gamers and IT pros ...